1.
Clinical significance of coagulation and fibrinolysis indicators in diagnosis of DIC in obstetrics
凝血与纤溶指标在产科弥漫性血管内凝血诊断中的意义
2.
The change and significance of coagulation and fibrinolytic function in children patients with sepsis
脓毒症患儿凝血与纤溶功能的变化及临床意义
3.
The Change of Coagulation and Fibrinolysis Related Factors Expression in HUVECs Infected with Dengue Virus 2;
登革病毒2型诱导血管内皮细胞凝血与纤溶相关分子表达的研究
4.
Pulmonary Thromboembolism and the Disturbances of Coagulation and Fibrinolysis;
肺动脉血栓栓塞症与凝血纤溶系统失衡
5.
Effects of Thrombin-activable Fibrinolysis Inhibitor and Hirudin on Fibrinolysis;
凝血酶激活的纤溶抑制剂与水蛭素对纤溶的影响
6.
Obsjective to investigate the relationship of the nephritic syndrome and the parameters of coagulation and fibrolysis.
目的探讨肾病综合征与凝血及纤溶指标的关系。
7.
Changes of Coagulative and Fibrinolytic Parameters in Coronary Heart Disease;
凝血及纤溶指标的变化与冠心病的关系
8.
Clinical Study the Relation CHD Syndrome Differentiation with Coagulation and Fibrinolysis System
冠心病辨证与血凝纤溶系统关系的临床研究
9.
Relationship between Thrombin Activated Fibrinolysis Inhibitor in Plasma and Vascular Complication in Type 2 Diabetes;
血浆凝血酶激活的纤溶抑制物与2型糖尿病血管并发症的关系
10.
A Correlative Study of Coagulation、Fibrinolitic System and Cerebral Vasospasm、Rebleeding in Subarachoid Haemorrhage;
SAH患者凝血及纤溶动态变化与迟发性血管痉挛、再出血的相关研究
11.
The Correlation between Disorders of Throm-fibrinolysis System Mediated by Thrombospondin-1(TSP-1) with Tubulointerstitial Fibrosis in Remnant Renal Tissues of 5/6 Nephrectomy Young Rats;
幼鼠残肾组织TSP-1介导凝血纤溶与肾纤维化的相关性研究
12.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析
13.
Clinical and Experimental Study of Effect of Continuous Blood Purification on Thrombotic and Fibrinolytic Factors and Mechanism;
连续性血液净化对凝血纤溶因子影响及其机制的临床与实验研究
14.
Type2 Diabetic Hemoglutination, the Filament Dissolves with the Trunk Pathological Change Relations.;
2型糖尿病患者凝血、纤溶指标异常与大血管病变的关系
15.
A Study on Relationship between Serum Lipoprotein(a) Level, The Changes of Plasma Haemostatic and Fibrinolytic Activities and T2 Diabetic Nephropathy;
血清脂蛋白（a）水平和凝血纤溶的改变与2型糖尿病肾病关系的研究
16.
The Study of Relation between ACA and Coagulation, Fibrinogen Lysis, Immune Function in Malignant Hematologic Disease;
恶性血液病患者抗心磷脂抗体与凝血、纤溶、免疫机制相关性研究
17.
Study of the Relativity between Thrombin-activatable Fibrinolysis Inhibtor and Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性研究
18.
The Relationship between Thrombin-Activatable Fibrinolysis Inhibitor and Risk of Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性